The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1948, 59: 165-168.
Copyright © 1948 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eaton, F. D.
Right arrow Articles by Leonard, G. F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Eaton, F. D.
Right arrow Articles by Leonard, G. F.

Production of Anti-Haemophilus Influenzae Type b Rabbit Serum1

F. D. Eaton, E. G. Gerwe and G. F. Leonard

Bacteriological Production Laboratories of E. R. Squibb & Sons, New Brunswick, New Jersey

Abstract

Data from a study of six groups, containing two hundred rabbits each, hyperimmunized for the production of anti-Haemophilus influenzae type b rabbit serum, when analyzed, were sufficient to determine the optimum bleeding periods. The rate of rise in potency of individual rabbit bleedings different from pooled large scale production bleedings, and such difference probably was due to individual variation in rabbit response and possibly poor response of animals in the production colony due to necessary production methods. From a practical point of view, it appears advisable to begin production bleedings at the eleventh or twelfth week of immunization.

Footnotes

1 This paper was "Read by Title" at the Society of American Bacteriologists 47th General Meeting in Philadelphia, Pa., May 16, 1947.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1948 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1948 by The American Association of Immunologists, Inc. All rights reserved.